Bruker (BRKR) Expected to Announce Quarterly Earnings on Tuesday

Bruker (NASDAQ:BRKR - Get Free Report) will likely be releasing its earnings data before the market opens on Tuesday, February 11th. Analysts expect Bruker to post earnings of $0.75 per share and revenue of $965.61 million for the quarter.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The medical research company reported $0.60 EPS for the quarter, missing the consensus estimate of $0.61 by ($0.01). Bruker had a return on equity of 21.52% and a net margin of 9.41%. The business had revenue of $864.40 million during the quarter, compared to analyst estimates of $866.46 million. During the same quarter last year, the firm posted $0.74 EPS. The company's revenue was up 16.4% compared to the same quarter last year. On average, analysts expect Bruker to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Bruker Stock Down 0.8 %

BRKR stock traded down $0.43 during midday trading on Friday, hitting $55.59. 1,409,422 shares of the company's stock were exchanged, compared to its average volume of 1,396,025. The stock has a market capitalization of $8.43 billion, a price-to-earnings ratio of 26.73, a price-to-earnings-growth ratio of 3.95 and a beta of 1.16. The company has a current ratio of 1.66, a quick ratio of 0.73 and a debt-to-equity ratio of 1.24. The firm has a 50 day moving average price of $58.32 and a 200-day moving average price of $61.07. Bruker has a 12-month low of $48.07 and a 12-month high of $94.86.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were issued a $0.05 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $0.20 annualized dividend and a yield of 0.36%. Bruker's dividend payout ratio is presently 9.62%.

Insider Transactions at Bruker

In other Bruker news, CEO Frank H. Laukien acquired 100,000 shares of Bruker stock in a transaction dated Monday, November 18th. The stock was acquired at an average cost of $50.14 per share, for a total transaction of $5,014,000.00. Following the completion of the transaction, the chief executive officer now owns 38,439,563 shares in the company, valued at approximately $1,927,359,688.82. This represents a 0.26 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 28.30% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on BRKR shares. Wells Fargo & Company dropped their target price on shares of Bruker from $78.00 to $75.00 and set an "overweight" rating for the company in a research report on Wednesday, November 6th. TD Cowen lowered their price objective on Bruker from $72.00 to $70.00 and set a "hold" rating for the company in a report on Wednesday, November 6th. UBS Group initiated coverage on Bruker in a report on Tuesday, December 10th. They set a "neutral" rating and a $66.00 target price on the stock. The Goldman Sachs Group upgraded Bruker from a "sell" rating to a "neutral" rating and set a $60.00 price target for the company in a report on Thursday, December 5th. Finally, Bank of America raised their price objective on Bruker from $78.00 to $80.00 and gave the stock a "buy" rating in a research note on Friday, December 13th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $74.45.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.